No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
RZLT Rezolute
- 4.390
- +0.160+3.78%
Close Dec 20 16:00 ET
- 4.390
- 0.0000.00%
Post 16:09 ET
254.37MMarket Cap-3.46P/E (TTM)
4.450High4.150Low357.18KVolume4.200Open4.230Pre Close1.56MTurnover0.71%Turnover RatioLossP/E (Static)57.94MShares6.18652wk High2.24P/B220.67MFloat Cap0.88052wk Low--Dividend TTM50.27MShs Float21.110Historical High--Div YieldTTM7.09%Amplitude0.720Historical Low4.373Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Express News | Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
RZLT Stock Rises on FDA's Orphan Designation for Rare Disease Drug
Sector Update: Health Care Stocks Higher Tuesday Afternoon
Yun Zhong, PhD, Joins Wedbush Securities as Senior Vice President, Equity Research, Biotechnology
Express News | FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (Rz358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
Heat List
US
Overall
Symbol
Price
% Chg
No Data